Longevity Medicine, Functional Wellness & Anti-Aging Insights from HormoneSynergy®

The triglyceride-to-HDL ratio is a useful clue to insulin resistance and triglyceride-rich lipoprotein metabolism, but it is not a stand-alone cardiovascular risk test. Its greatest value comes from interpreting it alongside fasting insulin, ApoB, remnant cholesterol, body composition, and the rest of the metabolic picture.

A standard lipid panel remains useful, but LDL-C alone can underestimate atherogenic particle burden. ApoB, non-HDL-C, Lp(a), metabolic markers, calculated risk, and selective plaque imaging can reveal what “normal cholesterol” misses.

LDL-C measures how much cholesterol is being carried inside LDL particles. ApoB provides an estimate of how many atherogenic particles are circulating. Most of the time the two move together, but when they do not, ApoB can reveal cardiovascular risk that a standard cholesterol panel may underestimate. Metabolic health, triglycerides, Lp(a), family history and imaging add important context without making atherogenic particle exposure irrelevant.

EPA and DHA can lower triglycerides, but formulation quality, concentration, dose and the person’s broader metabolic health all influence how omega-3 support should be used.

Type Fives often bring curiosity, independence, analysis, and a deep desire to understand complex systems. In health, that can be a real strength. But when knowledge stays in the mind and never becomes lived practice, the body may remain under-cared for. In longevity work, the growth path for Type Five is learning to translate insight into embodied action.

Magnesium plays an important role in insulin sensitivity, energy production, nervous system regulation, and sleep quality. This guide explains how magnesium fits into a physician-led longevity medicine approach to metabolic health, recovery, and healthy aging.

Many people don’t stay stuck because they don’t know what to do—they stay stuck because they keep repeating the same story about themselves. This article explores how identity, past experiences, and internal narratives shape behavior—and how awareness can begin to change it.

Muscle mass plays a major role in glucose disposal, insulin sensitivity, metabolic resilience, and healthy aging. In longevity medicine, preserving muscle is not just about strength or appearance. It is a core part of metabolic health.

Mitochondria drive energy production at the cellular level. When function declines, it may affect metabolism, recovery, and long-term resilience.

Fatty liver is often discovered by accident, sometimes with completely normal liver enzymes. Now called metabolic dysfunction-associated steatotic liver disease, or MASLD, it can offer an early look at insulin resistance, visceral fat, cardiovascular risk, and the metabolic changes occurring well before more obvious disease appears.

ALT and AST are commonly used liver enzymes, but even mild elevations may reflect deeper metabolic stress. In longevity medicine, they help provide early insight into liver and cardiometabolic health.

ApoA1 is the main protein component of HDL and helps reflect HDL function, cholesterol transport, and vascular resilience. It offers a more useful view of protective lipid physiology than HDL cholesterol alone